He aha te Ocrelizumab: Ngā Whakamahinga, te Inenga, Ngā Pānga taha me Ētahi Atu

He rongoā rongoā a Ocrelizumab e āwhina ana ki te whakaiti i te sclerosis maha (MS) mā te whai i ngā pūtau o te pūnaha ārai mate. Ka tukuna mā te whakaurunga IV i te tari o tō tākuta, i te pokapū whakaurunga rānei, te tikanga ia ono marama i muri i ō inenga tuatahi.

He ahunga whakamua nui tēnei rongoā i roto i te maimoatanga MS, e tuku ana i te tūmanako mō ngā tāngata e rua ngā momo hoki mai me ngā momo haere tonu o te mate. Mā te māramatanga ki te pēhea te mahi me te aha e tūmanakohia ana ka āwhina koe ki te whai i te māia ake mō tō haerenga maimoatanga.

He aha te Ocrelizumab?

He paturopi monoclonal a Ocrelizumab e whai ana i ngā pūtau B i roto i tō pūnaha ārai mate. Ko ēnei pūtau B te whai wāhi nui ki te tukanga autoimmune e whakangaro ana i ngā muka io i roto i te sclerosis maha.

Whakaarohia he rongoā tino tika e mahi ana pēnei i te pūwhiti ārahi, e rapu ana, e here ana ki ngā pūmua motuhake e kiia nei ko CD20 i runga i ngā pūtau B. Kia piri ana, ka āwhina i te whakaiti i te maha o ēnei pūtau ka taea te whakaputa mumura i roto i tō pūnaha io.

No tētahi akomanga e kiia nei ko ngā rongoā whakarerekē mate (DMTs) te rongoā, ko te tikanga kāore i te rongoā noa i ngā tohumate engari e mahi ana ki te whakaiti i te haere whakamua o te MS tonu. Nā tēnei ka rerekē rawa atu i ngā rongoā e āwhina ana i ngā tohumate motuhake pēnei i te ngāwari uaua, i te ngenge rānei.

He aha te Ocrelizumab e whakamahia ana mō?

Kua whakaaetia a Ocrelizumab e te FDA mō te rongoā i ngā momo e rua o te sclerosis maha. Koinei te rongoā tuatahi me te rongoā anake i whakaaetia mō te MS haere tonu tuatahi, e tino whai hua ana mō ngā tāngata e whai ana i tēnei momo mate.

Mō ngā momo hoki mai o te MS, kei roto i tēnei ko te MS hoki mai-whakawātea me te MS haere tonu tuarua. Koinei ngā momo e pā ana ki ngā tāngata i ngā whakaeke mārama, i ngā hokinga mai rānei e whai ana i ngā wā o te whakaora, o te pūmau rānei.

Ka tohutohu pea tō tākuta i te ocrelizumab mēnā kāore anō koe i whai hua i ētahi atu rongoā MS, mēnā rānei kei a koe te primary progressive MS he iti noa iho ētahi atu kōwhiringa. I ētahi wā ka kōwhiria hei rongoā tuatahi mō te hunga whai MS e kaha ana te hoki mai.

Me pēhea te mahi a te Ocrelizumab?

Ka mahi te Ocrelizumab mā te whakaiti i ngā pūtau B, he pūtau ārai mate e whai wāhi ana ki te mumura i te MS. E kiia ana he huarahi kaha ki te rongoā MS, he kaha ake i ētahi rongoā waha engari kāore i te whānui pērā i ētahi atu rongoā werohanga.

Ka herea te rongoā ki ngā pūmua CD20 i te mata o ngā pūtau B, ka tohu i a rātou kia whakangaromia e tō pūnaha ārai mate. Ka tino whakaiti tēnei tukanga i te maha o ngā pūtau B e huri haere ana i tō tinana mō ētahi marama.

Ko te mea e whai hua ana tēnei huarahi ko te aro ki ngā pūtau ārai mate e tino whai wāhi ana ki te haere whakamua o te MS i te wā e waiho ana ētahi atu wāhanga o tō pūnaha ārai mate kia tū tonu. Ko te whakaiti i ngā pūtau B te nuinga ka roa mō ētahi marama, koinei te take e hoatu ana te rongoā ia ono marama.

I roto i ētahi wiki i muri i te rongoā, ka iti rawa ngā pūtau B kei roto i tō pūnaha. I te roanga o te wā, ka hoki mai ēnei pūtau, engari ka taea tonu te pānga o te rongoā ki te whakaiti i te haere whakamua o te MS ahakoa te whakaora o ngā pūtau B.

Me pēhea taku tango i te Ocrelizumab?

Ka hoatu te Ocrelizumab mā te werohanga IV anake i te whare hauora, kāore rawa i te kāinga. Ko tō horopeta tuatahi te nuinga ka wehea kia rua ngā werohanga ka hoatu i te rua wiki te tawhiti, ā, ka roa ia werohanga mō te 2.5 ki te 3.5 hāora.

I mua i ia werohanga, ka whiwhi koe i ngā rongoā i mua hei āwhina i te ārai i ngā tauhohenga werohanga. Ko te nuinga o ēnei ko te antihistamine pērā i te diphenhydramine, he corticosteroid pērā i te methylprednisolone, ā, i ētahi wā ko te acetaminophen. Ka āwhina ēnei rongoā i tō tinana kia pai ake te aro ki te werohanga.

Kāore koe e hiahia ki te tango i te ocrelizumab me te kai i te mea ka tukuna tika ki roto i tō toto. Heoi, ko te kai i te kai mama i mua i tō tūpono ki te whakauru ka āwhina i a koe kia pai ake te noho i te wā o te tikanga roa.

I te wā o te whakauru, ka mātakitaki ngā kaimahi hauora i a koe mō ngā urupare. Ka tukuna te rongoā i te tuatahi, ā, ka piki ake te reiti ki te pai tō tinana ki te rongoā. Ka taea e te nuinga o te tangata te pānui, te whakamahi i tō rātou waea, te moe rānei i te wā o te whakauru.

Kia Pēhea te Roa e Tango ai au i te Ocrelizumab?

Ko te Ocrelizumab te tikanga he rongoā wā-roa ka haere tonu koe i te wā e āwhina ana i tō MS me te pai o tō tinana ki te rongoā. Ka noho te nuinga o te tangata ki runga i tēnei rongoā mō ngā tau, me te aroturuki i ngā wā katoa kia mōhio kei te haumaru tonu, kei te whai hua hoki.

Ka arotake tō tākuta i tō urupare ki te rongoā ia ono marama, i te wā o tō whakauru e whai ake nei. Ka titiro rātou ki ngā āhuatanga pēnei i ngā hokinga hou, ngā huringa MRI, te piki haere o te hauātanga, me ngā pānga taha e pā ana ki a koe.

Ka hiahia pea ētahi tangata ki te whakamutu i te ocrelizumab mēnā ka whanake ngā mate kino, ētahi momo mate pukupuku, rānei, ngā urupare whakauru kino. Ka kōrero tō tākuta i ēnei tūponotanga ki a koe, me te aroturuki mō ngā tohu e tika ana kia whakamutua te rongoā.

Ko te whakatau ki te haere tonu, ki te whakamutu rānei i te ocrelizumab me mahi tonu tahi me tō tohunga MS, me te whakatau i ngā painga e whiwhi ana koe ki ngā tūponotanga, ki ngā pānga taha rānei e pā ana ki a koe.

He Aha ngā Pānga Taha o te Ocrelizumab?

Pērā i ngā rongoā katoa, ka taea e te ocrelizumab te pānga taha, ahakoa he maha ngā tāngata e pai ana ki te rongoā. Ko ngā pānga taha tino noa e pā ana ki te tukanga whakauru me te piki haere o te tūponotanga ki ngā mate.

Koinei ngā pānga taha e pūrongohia ana e koe:

• Ngā pānga o te weronga pēnei i te whero o te kiri, te mānukanuka, te kirika ngawari rānei i te wā, i muri tata rānei i te rongoā
• Ngā mate o te ara rāhaua o runga pēnei i te makariri, i ngā mate rānei o te ihu
• Ngā mate kiri, ngā pakarutanga rānei o te herpes waha
• Te ngenge ka roa pea mō ētahi rā i muri i te weronga
• Te ānini, te mamae ngawari rānei o te tinana
• Te whakapairuaki, te raru rānei o te kōpū

Ko ēnei pānga taha noa e taea ana te whakahaere, ā, he maha ngā wā ka pai ake i te wā e urutau ana tō tinana ki te rongoā.

Ko ngā pānga taha nui ake, engari he iti noa iho te pā, e hiahia ana kia āta tirohia e te tākuta, ā, ko ēnei:

• Ngā pānga weronga nui, me te uaua ki te hā, te pupuhi nui, te mamae rānei o te uma
• Ngā tohu o ngā mate nui pēnei i te kirika tonu, te ngenge nui, ngā tohu rānei kāore i te noa
• Te leukoencephalopathy multifocal haere tonu (PML), he mate roro onge
• Te whakahohenga anō o te Hepatitis B i roto i ngā tāngata i pā ki tēnei mate i mua
• Ētahi momo mate pukupuku, ina koa te mate pukupuku u

Ka āta titiro tō rōpū hauora ki a koe mō ēnei raruraru onge, engari nui, mā ngā whakamātautau toto me ngā arotake auau.

Ko wai kāore e tika kia tango Ocrelizumab?

Kāore a Ocrelizumab e tika ana mō te katoa e pā ana ki te MS. Ka āta arotake tō tākuta i tō hītori hauora kia whakatau mēnā he haumaru tēnei rongoā mōu.

Kāore koe e tika kia tango ocrelizumab mēnā he mate hepatitis B tō, nā te mea ka taea e te rongoā te whakahohe anō i tēnei huaketo kia tino kaha. Me whakamātautau toto koe kia tirohia mō te hepatitis B i mua i te tīmatanga o te rongoā.

Ko ngā tāngata e pā ana ki ngā mate nui, me tatari kia tino rongoatia ēnei i mua i te tīmatanga o te ocrelizumab. Kei roto i tēnei ngā mate huakita, huaketo, harore rānei ka kaha ake i te wā e pēhia ana tō pūnaha ārai mate.

Mēnā i pā mai ō pūngāwerewere nui ki te ocrelizumab, ki ngā rongoā rite rānei i mua, kāore tēnei rongoā i te tūtohutia. Mā tō tākuta e kōrero ngā kōwhiringa kē atu, tērā pea he haumaru ake mōu.

Kaua ngā wāhine hapū e whiwhi ocrelizumab, nā te mea ka pā pea ki te pēpi e tipu ana. Mēnā kei te whakamahere koe kia hapū, kōrerohia tēnei ki tō tākuta i mua i te wā, nā te mea ka pā te rongoā ki tō pūnaha ārai mate mō ngā marama i muri i tō horopeta whakamutunga.

Ngā Ingoa Waitohu o Ocrelizumab

Ka hokona te Ocrelizumab i raro i te ingoa waitohu Ocrevus i te United States me te nuinga o ētahi atu whenua. Koinei anake te ingoa waitohu e wātea ana i tēnei wā, kāore anō he momo rongoā whānui o tēnei rongoā.

Ka hangaia te Ocrevus e Genentech i te US me Roche i ētahi atu whenua. He wāhanga ngātahi ngā kamupene e rua o te rōpū rongoā kotahi, nō reira he rite tonu te rongoā ahakoa i hea i hangaia ai.

I te wā e kōrero ana koe i tō rongoā ki ngā kaiwhakarato hauora, ki ngā kamupene inihua rānei, ka rongo pea koe i ngā ingoa e rua e whakamahia ana i te wā kotahi. E pai ana ētahi tākuta ki te whakamahi i te ingoa whānui (ocrelizumab) i te wā e whakamahi ana ētahi atu i te ingoa waitohu (Ocrevus).

Ngā Kōwhiringa Kē atu mō te Ocrelizumab

He maha ētahi atu rongoā ka taea te rongoā i te MS, ahakoa ko te kōwhiringa pai rawa atu ka whakawhirinaki ki tō momo MS me ō āhuatanga takitahi. Mā tō tākuta koe e āwhina ki te whakatau i ngā painga me ngā ngoikoretanga o ia kōwhiringa.

Mō te MS e hoki mai ana, ko ngā kōwhiringa kē atu ko ngā rongoā waha pēnei i te fingolimod (Gilenya), dimethyl fumarate (Tecfidera), teriflunomide rānei (Aubagio). He māmā ake te tango i ēnei, engari kāore pea i te whai hua mō te mate tino kaha.

Ko ētahi atu rongoā weronga ko te natalizumab (Tysabri) me te alemtuzumab (Lemtrada), e mahi rerekē ana i te ocrelizumab. Ka hoatu te Natalizumab ia marama, i te wā e uru ana te alemtuzumab ki ngā akoranga rongoā e rua i te tau kotahi.

Mō te MS haere tonu tuatahi, ko te ocrelizumab te rongoā kotahi kua whakaaetia e te FDA i tēnei wā, ā, koinei te paerewa koura mō tēnei momo mate. Heoi, ka whakaaro pea ētahi tākuta ki te whakamahi i ētahi atu rongoā i waho i te tapanga i ētahi āhuatanga motuhake.

He Pai Anei te Ocrelizumab i te Rituximab?

He rite ngā rongoā o te ocrelizumab me te rituximab e whai ana i ngā pūtau B, engari i hangaia te ocrelizumab, ā, i whakaaetia mō te rongoā MS. Ko te rituximab te mea nui e whakamahia ana mō ētahi momo mate pāwera me ngā mate ā-tinana, ahakoa kua whakamahia e ētahi tākuta i waho i te tapanga mō te MS.

E kiia ana he pai ake te ocrelizumab i te rituximab, me ngā whakarerekētanga ka waiho pea kia haumaru ake, kia whai hua ake mō te MS. I hangaia kia iti ake te immunogenic, ko te tikanga he iti ake te tūponotanga o tō tinana ki te whakawhanake i ngā paturopi ki a ia.

Ko ngā raraunga whakamātautau haumanu mō te ocrelizumab i te MS he nui ake i te rituximab, e hoatu ana ki ngā tākuta ngā kōrero pai ake mō tōna whai huatanga me te haumarutanga. Nō reira, ko te ocrelizumab te kōwhiringa pai mō te nuinga o ngā tohunga MS.

Heoi, ka whakamahia pea te rituximab i ētahi wā ki te kore e wātea te ocrelizumab, ki te kore rānei e hipokina e te inihua, i te mea he rite tonu te mahi a ngā rongoā e rua. Ka āwhina tō tākuta i a koe ki te mārama ko tēhea kōwhiringa pea te mea pai mō tō āhuatanga motuhake.

Ngā Pātai Auau mō te Ocrelizumab

He Haumaru Anei te Ocrelizumab mō te Hunga e Mate Pāwera ana?

Ka taea te whakamahi i te ocrelizumab i te nuinga o te wā i roto i te hunga e mate pāwera ana, engari me mahi tahi tō kaimātai ngākau me tō neurologist i tō manaakitanga. Ko te āwangawanga nui ko te mea ka pōrearea pea ngā tauhohenga whakauru i tō ngākau.

I mua i te tīmatanga o te rongoā, ka arotake tō tākuta i tō āhuatanga ngākau, ā, ka tūtohu pea i te aroturuki atu i ngā whakaurunga. Ko ētahi tāngata e raru ana i te ngākau nui pea me whakawhiwhi i ā rātou whakaurunga i te pōturi ake, i roto rānei i te hōhipera, kaua i te pokapū whakauru i waho.

He aha taku mahi ki te ngaro ohorere ahau i te horopeta o Ocrelizumab?

Whakapā atu ki te tari o tō tākuta i te wā e mōhio ana koe kua ngaro i a koe tō rārangi whakawhiwhi. Mā rātou koe e āwhina ki te whakarite anō i te wā e taea ai, i roto i ngā wiki ruarua i muri i te rā i ngaro ai.

Ko te ngaro i ngā horopeta ka whakaiti i te whai huatanga o te rongoā, ā, ka taea pea te tuku i te mahi MS kia hoki mai. Heoi, kaua e mataku ki te ngaro koe i tētahi rārangi i te mea he mate, he ētahi atu āhuatanga rānei. Ka mahi tō rōpū hauora ki a koe kia hoki mai ki te ara haumaru.

He aha taku mahi ki te whai urupare kino ahau i te wā o te whakawhiwhi?

Kōrero atu ki tō nēhi whakawhiwhi i te wā tonu ki te pā mai ētahi tohumate e pā ana ki a koe i te wā o te maimoatanga. Ko ngā tohu noa o ngā urupare whakawhiwhi ko te whero o te kiri, te mānukanuka, te uaua ki te hā, te pōkae o te uma, te ngoikore rānei.

Kua whakangungua ngā kaimahi hauora ki te whakahaere i ēnei āhuatanga, ā, ka puhoi, ka mutu rānei te whakawhiwhi, ka hoatu ki a koe ētahi atu rongoā, ka mātakitaki tata ki a koe. Ko te nuinga o ngā urupare whakawhiwhi ka taea te whakahaere, ā, kāore e ārai i a koe ki te whakaoti i te maimoatanga, ahakoa ka roa pea.

Āhea e taea ai e au te whakamutu i te tango Ocrelizumab?

Ko te whakatau ki te whakamutu i te ocrelizumab me mahi tonu ki tō tohunga MS, kaua e mahi anake. Kāore he wā i mua i te whakatau mō te maimoatanga, i te mea he maha ngā tāngata e whai hua ana i te noho tonu i runga i te rongoā mō te wā roa.

Ka tūtohu pea tō tākuta ki te whakamutu i te mea ka whanake ētahi pānga taha nui, ki te kore e kaha tō MS mō te wā roa, ki te hiahia rānei koe ki te tīmata i tētahi whānau. Mā rātou koe e āwhina ki te whakatau i ngā tūponotanga me ngā painga o te haere tonu ki te whakamutu rānei i te maimoatanga.

Ka taea e au te whiwhi kano ārai mate i te wā e tango ana i te Ocrelizumab?

Ka taea e koe te whiwhi i te nuinga o ngā kano ārai mate i te wā e tango ana i te ocrelizumab, engari ka iti ake pea te whai hua i te mea kua pēhia tō pūnaha ārai mate. Ka tūtohu tō tākuta ki te whakaoti i ngā kano ārai mate e hiahiatia ana i mua i te tīmatanga o te maimoatanga i te wā e taea ai.

Me karo ngā kano ārai mate ora i te wā e tango ana i te ocrelizumab, tērā pea ka pā mai ngā mate. Kei roto i tēnei ko ngā kano ārai mate pērā i te kano ārai mate rewharewha ora, MMR, me te kano ārai mate varicella (pāwera heihei). Heoi anō, he haumaru te nuinga o ngā kano ārai mate korekore pērā i te werohanga rewharewha auau, ā, e tūtohutia ana.